...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: from J4P on SH “ "I will go out on a limb with a prediction, but please follow my line of reasoning”

"....BoM2 is fast tracked with 1,000,000 patients taking ABL.....Why 1,000,000, approximate number of patients hospitalized world wide (my guess)."

????? Are you suggestion BoM2 trial will be a 1,000,000 patient trial? Or are you estimating the number of patients hospitalized worldwide with Covid-19? If it's the former, I suggest you re-evaluate the typical size of Phase 3 cardiovascular outcomes trials and the cost associated. It is hard to follow your post because it seems you are combining BoM2 and COVID-19 issues.

BDAZ

Share
New Message
Please login to post a reply